SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BIOA

BioAge Labs, Inc.
NASDAQHealth Care

Latest close: 4.84 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 5, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record13915 flagged findings
Reported transactions (Form 4)80since Sep 27, 2024 · and 35 other holdings
Corporate events (8-K)3since Sep 27, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-08share offering or dilution eventrecentOpen filing ↗
    “…filed a universal shelf registration statement on Form S-3 (the “Registration Statement”) with the SEC, as amended on November 5,…”
    +1 more passage from the same document
    • “…S-3 (the “Registration Statement”) with the SEC, as amended on November 5, 2025, and entered into a sales agreement with Leerink…”
  • 2026-03-24capital return (buybacks/dividends)recentOpen filing ↗
    “…the method used to determine such rate or rates; • the date or dates from which interest, if any, will be payable and any…”
    +1 more passage from the same document
    • “…the offering price, if any, and the exercise price are payable; • if applicable, a discussion of material U.S. federal income tax…”
  • 2026-03-24share offering or dilution eventrecentOpen filing ↗
    “…trials in order to seek regulatory approval, and we anticipate needing to raise additional capital to complete the development…”
    +1 more passage from the same document
    • “…our common stock, preferred stock or debt securities and/or units consisting of some or all of these securities, in one or…”
  • 2026-03-24reverse splitrecentOpen filing ↗
    “…(“ASU”) promulgated by the Financial Accounting Standards Board (“FASB”). The consolidated financial statements include the accounts…”
    +1 more passage from the same document
    • “…and its wholly owned subsidiary, BioAge Labs PTY LTD. BioAge Labs PTY LTD was incorporated in Australia in December 2020. All…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 139)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 2, 268-K ↗Current report · Other events
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Cormorant Asset Management, LP · 5.4% · event on Jun 30, 26 · amendment
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Results
  • Jul 1, 26Form 4 ↗Insider transaction
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Jun 12, 268-K ↗Current report · Shareholder vote results
  • Jun 12, 26Form 4 ↗Insider transaction
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · VK Services, LLC · 4.0% · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Cormorant Asset Management, LP · 6.5% · event on Mar 31, 26 · amendment
  • May 8, 268-K ↗Current report · Results
  • May 8, 2610-Q ↗Quarterly report
  • Apr 27, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.0% · event on Mar 31, 26
  • Apr 24, 26Form 4 ↗Insider transaction
  • Apr 21, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 21, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 3, 26Form 4 ↗Insider transaction
  • Apr 1, 26Form 144 ↗Notice of proposed sale
  • Mar 24, 26S-3ASR ↗Securities offering

139 filings on record, the oldest from Jun 28, 24.

Listing the 25 most recent filings of the 139 on record.

8-Ks, explained

Structure3
  • Jan 22, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 27, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Kristen Fortney7.2%Dec 31, 25SCHEDULE 13G/A ↗
  • Cormorant Asset Management, LP5.4%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • BlackRock, Inc.5.0%Mar 31, 26SCHEDULE 13G ↗
  • VK Services, LLC4.0%May 15, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
  • RA Capital Management, L.P.3.7%Dec 31, 24SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
show one more holderhide
  • ADAR1 Capital Management, LLC0.4%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jun 30, Barton Shane filed notice of intent to sell up to $509K. That is about 0.05% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $509K on Jun 30, per their Form 4. That is 100% of the shares announced.

View notice (Form 144) ↗+1 more recent notices · 1 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 30, 26Sell$509KShane BartonPrincipal Accounting Officer↗
  • Jun 29, 26Sell$1.1MShane BartonPrincipal Accounting Officer↗
  • Apr 1, 26Sell$157KPAUL D RUBINChief Medical Officer↗
  • Mar 2, 26Sell$151KPAUL D RUBINChief Medical Officer↗
  • Feb 2, 26Sell$139KPAUL D RUBINChief Medical Officer↗
  • Jan 13, 26Sell$165KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 13, 26Sell$86KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 13, 26Sell$240KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 13, 26Sell$41KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 13, 26Sell$4.2MKristen FortneyChief Executive Officer↗
  • Jan 2, 26Sell$95KPAUL D RUBINChief Medical Officer↗
  • Dec 9, 25Sell$216KPAUL D RUBINChief Medical Officer↗

There are 5 more transactions in this stretch.

Stock compensation, tax and giftsshow the 23 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Compensation$47KShane BartonPrincipal Accounting Officer↗
  • Jun 30, 26Compensation$34KShane BartonPrincipal Accounting Officer↗
  • Jun 30, 26Compensation$17KShane BartonPrincipal Accounting Officer↗
  • Jun 30, 26Compensation$34KShane BartonPrincipal Accounting Officer↗
  • Jun 29, 26Compensation$101KShane BartonPrincipal Accounting Officer↗
  • Jun 29, 26Compensation$61KShane BartonPrincipal Accounting Officer↗
  • Jun 29, 26Compensation$39KShane BartonPrincipal Accounting Officer↗
  • Jun 29, 26Compensation$62KShane BartonPrincipal Accounting Officer↗
  • Apr 23, 26Compensation$16KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Apr 1, 26Compensation$22KPAUL D RUBINChief Medical Officer↗
  • Apr 1, 26Compensation$22KPAUL D RUBINChief Medical Officer↗
  • Mar 2, 26Compensation$22KPAUL D RUBINChief Medical Officer↗
  • Mar 2, 26Compensation$13KPAUL D RUBINChief Medical Officer↗
  • Mar 1, 26Compensation$16KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Feb 2, 26Compensation$22KPAUL D RUBINChief Medical Officer↗
  • Feb 2, 26Compensation$13KPAUL D RUBINChief Medical Officer↗
  • Feb 1, 26Compensation$16KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 16, 26Compensation$16KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 13, 26Compensation$227KDOV A GOLDSTEIN MDChief Financial Officer↗
  • Jan 2, 26Compensation$22KPAUL D RUBINChief Medical Officer↗
  • Jan 2, 26Compensation$13KPAUL D RUBINChief Medical Officer↗
  • Dec 9, 25Compensation$118KPAUL D RUBINChief Medical Officer↗
  • Dec 4, 25Compensation$283KPAUL D RUBINChief Medical Officer↗

The full record holds 56 transactions and goes back to Mar 26, 24.

Its sector and its market

BioAge Labs, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From BioAge Labs, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow BioAge Labs, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
139 documents on file, from Jun 28, 2024 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

BioAge Labs, Inc. (BIOA): stock price history, insider trades and SEC filings — HornScout